Effects of n-3 fatty acids on the NMR profile of plasma lipoproteins.
The effects of fish oil supplementation (14.5 g n-3 fatty acids/day) on plasma lipoprotein particles in healthy volunteers were assessed by high resolution 13C and 1H nuclear magnetic resonance (NMR) spectroscopy. Resonances not previously observed in the 13C and 1H spectra of plasma and isolated lipoproteins were detected after fish oil ingestion. The 13C resonances, centered at 14.3, 127.1, and 131.6 ppm, have been assigned to specific carbon groups (CH3-CH2-CH = CH-, CH3-CH2-CH = CH-CH2-, CH3-CH2-CH = CH-CH2-, respectively) in eicosapentaenoic acid (C20:5n-3) and docosahexaenoic (C22:6n-3) DHA. The new lipid resonance observed in the 1H spectra of plasma (0.941 ppm) is consistent with the incorporation of these n-3 fatty acids into lipoprotein particles. The presence of increased EPA and DHA in plasma lipids was confirmed by gas-liquid chromatography. A marked reduction in the intensity of the methylene signal from very low density lipoproteins (VLDL) was also observed with fish oil. This reduction arises from a decrease in plasma triglyceride concentration (ca. 18%) and a reduction in the number of VLDL particles. Transverse relaxation studies of isolated VLDL and low density lipoprotein (LDL) showed significant elevation in the T2 of the -(CH2)n- and CH3- signals from non-n-3 fatty acids. The relaxation characteristics and signal intensity of the novel 1H peak (0.941 ppm) point to the existence of n-3 enriched microenvironments within lipoprotein particles. These findings suggest that incorporation of EPA and DHA into VLDL and LDL, after fish oil ingestion, leads to significant alteration in the molecular architecture of lipoprotein particles.
Bell
J D
JD
NMR Unit, Hammersmith Hospital, London, United Kingdom.
Barnard
M L
ML
Parkes
H G
HG
Thomas
E L
EL
Brennan
C H
CH
Cunnane
S C
SC
Dagnelie
P C
PC
D000328:Adult; D002247:Carbon Isotopes; D015525:Fatty Acids, Omega-3 / Q000494:pharmacology*; D006801:Humans; D008075:Lipoproteins, HDL / Q000032:analysis / Q000097:blood / Q000187:drug effects; D008077:Lipoproteins, LDL / Q000032:analysis* / Q000097:blood / Q000187:drug effects; D008079:Lipoproteins, VLDL / Q000032:analysis* / Q000097:blood / Q000187:drug effects; D009682:Magnetic Resonance Spectroscopy; D014316:Tritium
D002247:Carbon Isotopes; D015525:Fatty Acids, Omega-3; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D014316:Tritium